{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:51:35Z","timestamp":1791258695649,"version":"4.1.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T00:00:00Z","timestamp":1362441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/nrneph.2013.35","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T10:08:39Z","timestamp":1362478119000},"page":"211-222","source":"Crossref","is-referenced-by-count":137,"title":["Angiogenesis and hypoxia in the kidney"],"prefix":"10.1038","volume":"9","author":[{"given":"Tetsuhiro","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"BFnrneph201335_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","volume":"41","author":"J Coresh","year":"2003","unstructured":"Coresh, J., Astor, B. C., Greene, T., Eknoyan, G. & Levey, A. S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 41, 1\u201312 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201335_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0140-6736(68)90589-8","volume":"2","author":"RA Risdon","year":"1968","unstructured":"Risdon, R. A., Sloper, J. C. & De Wardener, H. E. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2, 363\u2013366 (1968).","journal-title":"Lancet"},{"key":"BFnrneph201335_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1056\/NEJM199503093321006","volume":"332","author":"M Brezis","year":"1995","unstructured":"Brezis, M. & Rosen, S. Hypoxia of the renal medulla\u2014its implications for disease. N. Engl. J. Med. 332, 647\u2013655 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201335_CR4","first-page":"F910","volume":"259","author":"HJ Schurek","year":"1990","unstructured":"Schurek, H. J., Jost, U., Baumg\u00e4rtl, H., Bertram, H. & Heckmann, U. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am. J. Physiol. 259, F910\u2013F915 (1990).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph201335_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1440-1681.2006.04391.x","volume":"33","author":"PM O'Connor","year":"2006","unstructured":"O'Connor, P. M., Anderson, W. P., Kett, M. M. & Evans, R. G. Renal preglomerular arterial-venous O2 shunting is a structural antioxidant defence mechanism of the renal cortex. Clin. Exp. Pharmacol. Physiol. 33, 637\u2013641 (2006).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"BFnrneph201335_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1440-1681.2011.05531.x","volume":"38","author":"Y Kida","year":"2011","unstructured":"Kida, Y. & Duffield, J. S. Pivotal role of pericytes in kidney fibrosis. Clin. Exp. Pharmacol. Physiol. 38, 467\u2013473 (2011).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"BFnrneph201335_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet, P. & Jain, R. K. Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298\u2013307 (2011).","journal-title":"Nature"},{"key":"BFnrneph201335_CR8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1684\/ecn.2009.0170","volume":"20","author":"N Ferrara","year":"2009","unstructured":"Ferrara, N. VEGF-A: a critical regulator of blood vessel growth. Eur. Cytokine Netw. 20, 158\u2013163 (2009).","journal-title":"Eur. Cytokine Netw."},{"key":"BFnrneph201335_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"N Ferrara","year":"1997","unstructured":"Ferrara, N. & Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4\u201325 (1997).","journal-title":"Endocr. Rev."},{"key":"BFnrneph201335_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4161\/cam.22439","volume":"6","author":"M Peiris-Pag\u00e8s","year":"2012","unstructured":"Peiris-Pag\u00e8s, M. The role of VEGF 165b in pathophysiology. Cell Adh. Migr. 6, 561\u2013568 (2012).","journal-title":"Cell Adh. Migr."},{"key":"BFnrneph201335_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.devcel.2008.12.009","volume":"16","author":"LK Phng","year":"2009","unstructured":"Phng, L. K. et al. Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev. Cell 16, 70\u201382 (2009).","journal-title":"Dev. Cell"},{"key":"BFnrneph201335_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2008.661","volume":"75","author":"I Sakamoto","year":"2009","unstructured":"Sakamoto, I. et al. Lymphatic vessels develop during tubulointerstitial fibrosis. Kidney Int. 75, 828\u2013838 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR13","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/ki.2011.464","volume":"81","author":"Y Suzuki","year":"2012","unstructured":"Suzuki, Y. et al. Transforming growth factor-\u03b2 induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction. Kidney Int. 81, 865\u2013879 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/ki.2012.312","volume":"83","author":"AS Lee","year":"2012","unstructured":"Lee, A. S. et al. Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney Int. 83, 50\u201362 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.110.957332","volume":"122","author":"M Bry","year":"2010","unstructured":"Bry, M. et al. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation 122, 1725\u20131733 (2010).","journal-title":"Circulation"},{"key":"BFnrneph201335_CR16","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/cncr.24789","volume":"116","author":"JD Schwartz","year":"2010","unstructured":"Schwartz, J. D., Rowinsky, E. K., Youssoufian, H., Pytowski, B. & Wu, Y. Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1). Cancer 116, 1027\u20131032 (2010).","journal-title":"Cancer"},{"key":"BFnrneph201335_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2012.08.037","volume":"151","author":"J Jin","year":"2012","unstructured":"Jin, J. et al. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell 151, 384\u2013399 (2012).","journal-title":"Cell"},{"key":"BFnrneph201335_CR18","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1074\/jbc.270.22.13333","volume":"270","author":"AP Levy","year":"1995","unstructured":"Levy, A. P., Levy, N. S., Wegner, S. & Goldberg, M. A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270, 13333\u201313340 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201335_CR19","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1074\/jbc.271.5.2746","volume":"271","author":"AP Levy","year":"1996","unstructured":"Levy, A. P., Levy, N. S. & Goldberg, M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271, 2746\u20132753 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201335_CR20","first-page":"2165","volume":"37","author":"H Takagi","year":"1996","unstructured":"Takagi, H., King, G. L., Robinson, G. S., Ferrara, N. & Aiello, L. P. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest. Ophthalmol. Vis. Sci. 37, 2165\u20132176 (1996).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrneph201335_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm2639","volume":"10","author":"HG Augustin","year":"2009","unstructured":"Augustin, H. G., Koh, G. Y., Thurston, G. & Alitalo, K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Biol. 10, 165\u2013177 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrneph201335_CR22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1593\/neo.06127","volume":"8","author":"MW Olsen","year":"2006","unstructured":"Olsen, M. W. et al. Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure. Neoplasia 8, 364\u2013372 (2006).","journal-title":"Neoplasia"},{"key":"BFnrneph201335_CR23","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1158\/0008-5472.CAN-04-1054","volume":"64","author":"Y Xu","year":"2004","unstructured":"Xu, Y., Liu, Y. J. & Yu, Q. Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis. Cancer Res. 64, 6119\u20136126 (2004).","journal-title":"Cancer Res."},{"key":"BFnrneph201335_CR24","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1096\/fj.03-1466com","volume":"18","author":"HJ Lee","year":"2004","unstructured":"Lee, H. J. et al. Biological characterization of angiopoietin-3 and angiopoetin-4. FASEB J. 18, 1200\u20131208 (2004).","journal-title":"FASEB J."},{"key":"BFnrneph201335_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ncb1714","volume":"10","author":"S Fukuhara","year":"2008","unstructured":"Fukuhara, S. et al. Differential function of Tie2 at cell\u2013cell contacts and cell\u2013substratum contacts regulated by angiopoietin-1. Nat. Cell Biol. 10, 513\u2013526 (2008).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph201335_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ncb1715","volume":"10","author":"P Saharinen","year":"2008","unstructured":"Saharinen, P. et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell\u2013cell and cell\u2013matrix contacts. Nat. Cell Biol. 10, 527\u2013537 (2008).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph201335_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/sj.emboj.7601982","volume":"27","author":"H Kidoya","year":"2008","unstructured":"Kidoya, H. et al. Spatial and temporal role of the apelin\/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J. 27, 522\u2013534 (2008).","journal-title":"EMBO J."},{"key":"BFnrneph201335_CR28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/01.ASN.0000034910.58454.FD","volume":"13","author":"DH Kang","year":"2002","unstructured":"Kang, D. H. et al. Role of the microvascular endothelium in progressive renal disease. J. Am. Soc. Nephrol. 13, 806\u2013816 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000174072","volume":"19","author":"A Bohle","year":"1996","unstructured":"Bohle, A., Mackensen-Haen, S. & Wehrmann, M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press. Res. 19, 191\u2013195 (1996).","journal-title":"Kidney Blood Press. Res."},{"key":"BFnrneph201335_CR30","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1681\/ASN.V1271448","volume":"12","author":"DH Kang","year":"2001","unstructured":"Kang, D. H., Hughes, J., Mazzali, M., Schreiner, G. F. & Johnson, R. J. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J. Am. Soc. Nephrol. 12, 1448\u20131457 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/ki.2012.208","volume":"82","author":"LS Chawla","year":"2012","unstructured":"Chawla, L. S. & Kimmel, P. L. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int. 82, 516\u2013524 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nm.2144","volume":"16","author":"L Yang","year":"2010","unstructured":"Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V. & Bonventre, J. V. Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury. Nat. Med. 16, 535\u2013543 (2010).","journal-title":"Nat. Med."},{"key":"BFnrneph201335_CR33","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nm.2135","volume":"16","author":"W Bechtel","year":"2010","unstructured":"Bechtel, W. et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 16, 544\u2013550 (2010).","journal-title":"Nat. Med."},{"key":"BFnrneph201335_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1523-1755.2005.00085.x","volume":"67","author":"Y Ishii","year":"2005","unstructured":"Ishii, Y. et al. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int. 67, 321\u2013332 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR35","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1046\/j.1523-1755.2002.00631.x","volume":"62","author":"TA Sutton","year":"2002","unstructured":"Sutton, T. A., Fisher, C. J. & Molitoris, B. A. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 62, 1539\u20131549 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1523-1755.2004.761_5.x","volume":"66","author":"BA Molitoris","year":"2004","unstructured":"Molitoris, B. A. & Sutton, T. A. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int. 66, 496\u2013499 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR37","doi-asserted-by":"publisher","first-page":"F887","DOI":"10.1152\/ajprenal.00050.2001","volume":"281","author":"DP Basile","year":"2001","unstructured":"Basile, D. P., Donohoe, D., Roethe, K. & Osborn, J. L. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am. J. Physiol. Renal Physiol. 281, F887\u2013F899 (2001).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201335_CR38","doi-asserted-by":"publisher","first-page":"F688","DOI":"10.1152\/ajprenal.00452.2006","volume":"293","author":"M Horbelt","year":"2007","unstructured":"Horbelt, M. et al. Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am. J. Physiol. Renal Physiol. 293, F688\u2013F695 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201335_CR39","doi-asserted-by":"publisher","first-page":"10440","DOI":"10.1073\/pnas.0401339101","volume":"101","author":"T Kong","year":"2004","unstructured":"Kong, T., Eltzschig, H. K., Karhausen, J., Colgan, S. P. & Shelley, C. S. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of \u03b22 integrin gene expression. Proc. Natl Acad. Sci. USA 101, 10440\u201310445 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201335_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1681\/ASN.2005070757","volume":"17","author":"M Nangaku","year":"2006","unstructured":"Nangaku, M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. 17, 17\u201325 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR41","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/01.ASN.0000128047.13396.48","volume":"15","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto, M. et al. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J. Am. Soc. Nephrol. 15, 1574\u20131581 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR42","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/01.ASN.0000125614.35046.10","volume":"15","author":"K Manotham","year":"2004","unstructured":"Manotham, K. et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J. Am. Soc. Nephrol. 15, 1277\u20131288 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ki.2012.20","volume":"82","author":"I Grgic","year":"2012","unstructured":"Grgic, I. et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 82, 172\u2013183 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR44","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1046\/j.1523-1755.2002.00140.x","volume":"61","author":"A Priyadarshi","year":"2002","unstructured":"Priyadarshi, A. et al. Effects of reduction of renal mass on renal oxygen tension and erythropoietin production in the rat. Kidney Int. 61, 542\u2013546 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR45","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.2337\/diabetes.54.11.3282","volume":"54","author":"F Palm","year":"2005","unstructured":"Palm, F., Buerk, D. G., Carlsson, P. O., Hansell, P. & Liss, P. Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation. Diabetes 54, 3282\u20133287 (2005).","journal-title":"Diabetes"},{"key":"BFnrneph201335_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000091783","volume":"26","author":"M Goldfarb","year":"2006","unstructured":"Goldfarb, M. et al. Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance. Am. J. Nephrol. 26, 22\u201333 (2006).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph201335_CR47","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0002-9440(10)63249-X","volume":"165","author":"T Tanaka","year":"2004","unstructured":"Tanaka, T., Miyata, T., Inagi, R., Fujita, T. & Nangaku, M. Hypoxia in renal disease with proteinuria and\/or glomerular hypertension. Am. J. Pathol. 165, 1979\u20131992 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph201335_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1073\/pnas.0509459103","volume":"103","author":"M Safran","year":"2006","unstructured":"Safran, M. et al. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc. Natl Acad. Sci. USA 103, 105\u2013110 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201335_CR49","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/HYPERTENSIONAHA.111.171405","volume":"58","author":"ML Gloviczki","year":"2011","unstructured":"Gloviczki, M. L. et al. Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension 58, 1066\u20131072 (2011).","journal-title":"Hypertension"},{"key":"BFnrneph201335_CR50","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1681\/ASN.2007040420","volume":"19","author":"SC Textor","year":"2008","unstructured":"Textor, S. C. et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J. Am. Soc. Nephrol. 19, 780\u2013788 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR51","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng1294-345","volume":"8","author":"KA McAllister","year":"1994","unstructured":"McAllister, K. A. et al. Endoglin, a TGF-\u03b2 binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8, 345\u2013351 (1994).","journal-title":"Nat. Genet."},{"key":"BFnrneph201335_CR52","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1681\/ASN.2010111143","volume":"22","author":"T Inoue","year":"2011","unstructured":"Inoue, T. et al. Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J. Am. Soc. Nephrol. 22, 1429\u20131434 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR53","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/jmri.22501","volume":"33","author":"ZJ Wang","year":"2011","unstructured":"Wang, Z. J., Kumar, R., Banerjee, S. & Hsu, C. Y. Blood oxygen level-dependent (BOLD) MRI of diabetic nephropathy: preliminary experience. J. Magn. Reson. Imaging 33, 655\u2013660 (2011).","journal-title":"J. Magn. Reson. Imaging"},{"key":"BFnrneph201335_CR54","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ejrad.2011.03.045","volume":"81","author":"WJ Yin","year":"2012","unstructured":"Yin, W. J. et al. Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. Eur. J. Radiol. 81, 1426\u20131431 (2012).","journal-title":"Eur. J. Radiol."},{"key":"BFnrneph201335_CR55","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ki.1992.441","volume":"42","author":"LF Brown","year":"1992","unstructured":"Brown, L. F. et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 42, 1457\u20131461 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR56","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1681\/ASN.V961032","volume":"9","author":"M Simon","year":"1998","unstructured":"Simon, M. et al. Receptors of vascular endothelial growth factor\/vascular permeability factor (VEGF\/VPF) in fetal and adult human kidney: localization and 125I VEGF binding sites. J. Am. Soc. Nephrol. 9, 1032\u20131044 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR57","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","volume":"111","author":"V Eremina","year":"2003","unstructured":"Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707\u2013716 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201335_CR58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/08860220701813335","volume":"30","author":"N Futrakul","year":"2008","unstructured":"Futrakul, N., Butthep, P., Laohareungpanya, N., Chaisuriya, P. & Ratanabanangkoon, K. A defective angiogenesis in chronic kidney disease. Ren. Fail. 30, 215\u2013217 (2008).","journal-title":"Ren. Fail."},{"key":"BFnrneph201335_CR59","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1681\/ASN.2009010061","volume":"20","author":"GS Di Marco","year":"2009","unstructured":"Di Marco, G. S. et al. The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. J. Am. Soc. Nephrol. 20, 2235\u20132245 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR60","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0002-9440(10)61731-2","volume":"159","author":"Y Masuda","year":"2001","unstructured":"Masuda, Y. et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am. J. Pathol. 159, 599\u2013608 (2001).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph201335_CR61","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1097\/01.ASN.0000141038.28733.F2","volume":"15","author":"A Shimizu","year":"2004","unstructured":"Shimizu, A. et al. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis. J. Am. Soc. Nephrol. 15, 2655\u20132665 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR62","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1172\/JCI6740","volume":"104","author":"T Ostendorf","year":"1999","unstructured":"Ostendorf, T. et al. VEGF165 mediates glomerular endothelial repair. J. Clin. Invest. 104, 913\u2013923 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201335_CR63","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/sj.ki.5000439","volume":"69","author":"A Hara","year":"2006","unstructured":"Hara, A. et al. Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney Int. 69, 1986\u20131995 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR64","doi-asserted-by":"publisher","first-page":"F1648","DOI":"10.1152\/ajprenal.00099.2008","volume":"295","author":"EC Leonard","year":"2008","unstructured":"Leonard, E. C., Friedrich, J. L. & Basile, D. P. VEGF121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am. J. Physiol. Renal Physiol. 295, F1648\u2013F1657 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201335_CR65","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/sj.ki.5000294","volume":"69","author":"B Hohenstein","year":"2006","unstructured":"Hohenstein, B. et al. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 69, 1654\u20131661 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR66","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1469-7580.2005.00492.x","volume":"207","author":"M Guo","year":"2005","unstructured":"Guo, M. et al. A stereological study of the renal glomerular vasculature in the db\/db mouse model of diabetic nephropathy. J. Anat. 207, 813\u2013821 (2005).","journal-title":"J. Anat."},{"key":"BFnrneph201335_CR67","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1681\/ASN.2006010075","volume":"18","author":"E Liu","year":"2007","unstructured":"Liu, E. et al. Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J. Am. Soc. Nephrol. 18, 2094\u20132104 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR68","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.2353\/ajpath.2009.080792","volume":"175","author":"S Hakroush","year":"2009","unstructured":"Hakroush, S. et al. Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am. J. Pathol. 175, 1883\u20131895 (2009).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph201335_CR69","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ki.2010.64","volume":"77","author":"D Veron","year":"2010","unstructured":"Veron, D. et al. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int. 77, 989\u2013999 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR70","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.2337\/db08-0647","volume":"57","author":"CH Ku","year":"2008","unstructured":"Ku, C. H. et al. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes 57, 2824\u20132833 (2008).","journal-title":"Diabetes"},{"key":"BFnrneph201335_CR71","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.2337\/DB11-1655","volume":"61","author":"GA Sivaskandarajah","year":"2012","unstructured":"Sivaskandarajah, G. A. et al. Vegfa protects the glomerular microvasculature in diabetes. Diabetes 61, 2958\u20132966 (2012).","journal-title":"Diabetes"},{"key":"BFnrneph201335_CR72","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2006121304","volume":"18","author":"MT Lindenmeyer","year":"2007","unstructured":"Lindenmeyer, M. T. et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J. Am. Soc. Nephrol. 18, 1765\u20131776 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR73","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1681\/ASN.2008020243","volume":"20","author":"AS Woolf","year":"2009","unstructured":"Woolf, A. S., Gnudi, L. & Long, D. A. Roles of angiopoietins in kidney development and disease. J. Am. Soc. Nephrol. 20, 239\u2013244 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR74","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1681\/ASN.V1161055","volume":"11","author":"HT Yuan","year":"2000","unstructured":"Yuan, H. T., Suri, C., Landon, D. N., Yancopoulos, G. D. & Woolf, A. S. Angiopoietin-2 is a site-specific factor in differentiation of mouse renal vasculature. J. Am. Soc. Nephrol. 11, 1055\u20131066 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR75","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/dvdy.1170","volume":"222","author":"M Kolatsi-Joannou","year":"2001","unstructured":"Kolatsi-Joannou, M., Li, X. Z., Suda, T., Yuan, H. T. & Woolf, A. S. Expression and potential role of angiopoietins and Tie-2 in early development of the mouse metanephros. Dev. Dyn. 222, 120\u2013126 (2001).","journal-title":"Dev. Dyn."},{"key":"BFnrneph201335_CR76","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/01.ASN.0000115397.22519.03","volume":"15","author":"SC Satchell","year":"2004","unstructured":"Satchell, S. C., Anderson, K. L. & Mathieson, P. W. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J. Am. Soc. Nephrol. 15, 566\u2013574 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR77","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1681\/ASN.2006101093","volume":"18","author":"B Davis","year":"2007","unstructured":"Davis, B. et al. Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J. Am. Soc. Nephrol. 18, 2320\u20132329 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR78","first-page":"201","volume":"38","author":"N Futrakul","year":"2008","unstructured":"Futrakul, N., Butthep, P. & Futrakul, P. Altered vascular homeostasis in chronic kidney disease. Clin. Hemorheol. Microcirc. 38, 201\u2013207 (2008).","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"BFnrneph201335_CR79","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1046\/j.1523-1755.2002.00381.x","volume":"61","author":"HT Yuan","year":"2002","unstructured":"Yuan, H. T., Tipping, P. G., Li, X. Z., Long, D. A. & Woolf, A. S. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis. Kidney Int. 61, 2078\u20132089 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR80","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1681\/ASN.2006020109","volume":"17","author":"W Kim","year":"2006","unstructured":"Kim, W. et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J. Am. Soc. Nephrol. 17, 2474\u20132483 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR81","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10456-008-9101-9","volume":"11","author":"P ten Dijke","year":"2008","unstructured":"ten Dijke, P., Goumans, M. J. & Pardali, E. Endoglin in angiogenesis and vascular diseases. Angiogenesis 11, 79\u201389 (2008).","journal-title":"Angiogenesis"},{"key":"BFnrneph201335_CR82","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672\u2013683 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201335_CR83","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa055352","volume":"355","author":"RJ Levine","year":"2006","unstructured":"Levine, R. J. et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355, 992\u20131005 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201335_CR84","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha, S. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642\u2013649 (2006).","journal-title":"Nat. Med."},{"key":"BFnrneph201335_CR85","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/01.HYP.0000037429.73954.27","volume":"40","author":"A Rodriguez-Pena","year":"2002","unstructured":"Rodriguez-Pena, A. et al. Endoglin upregulation during experimental renal interstitial fibrosis in mice. Hypertension 40, 713\u2013720 (2002).","journal-title":"Hypertension"},{"key":"BFnrneph201335_CR86","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1681\/ASN.V1271434","volume":"12","author":"DH Kang","year":"2001","unstructured":"Kang, D. H. et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J. Am. Soc. Nephrol. 12, 1434\u20131447 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR87","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1159\/000198235","volume":"111","author":"C Hugo","year":"2009","unstructured":"Hugo, C. & Daniel, C. Thrombospondin in renal disease. Nephron Exp. Nephrol. 111, e61\u2013e66 (2009).","journal-title":"Nephron Exp. Nephrol."},{"key":"BFnrneph201335_CR88","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2174\/1381612033391342","volume":"9","author":"B Vailhe","year":"2003","unstructured":"Vailhe, B. & Feige, J. J. Thrombospondins as anti-angiogenic therapeutic agents. Curr. Pharm. Des. 9, 583\u2013588 (2003).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrneph201335_CR89","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O'Reilly","year":"1994","unstructured":"O'Reilly, M. S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315\u2013328 (1994).","journal-title":"Cell"},{"key":"BFnrneph201335_CR90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0014-5793(04)00297-2","volume":"564","author":"J Sima","year":"2004","unstructured":"Sima, J., Zhang, S. X., Shao, C., Fant, J. & Ma, J. X. The effect of angiostatin on vascular leakage and VEGF expression in rat retina. FEBS Lett. 564, 19\u201323 (2004).","journal-title":"FEBS Lett."},{"key":"BFnrneph201335_CR91","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1681\/ASN.2005020217","volume":"17","author":"SX Zhang","year":"2006","unstructured":"Zhang, S. X. et al. Therapeutic potential of angiostatin in diabetic nephropathy. J. Am. Soc. Nephrol. 17, 475\u2013486 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR92","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/MOH.0b013e328345a180","volume":"18","author":"S Anand","year":"2011","unstructured":"Anand, S. & Cheresh, D. A. MicroRNA-mediated regulation of the angiogenic switch. Curr. Opin. Hematol. 18, 171\u2013176 (2011).","journal-title":"Curr. Opin. Hematol."},{"key":"BFnrneph201335_CR93","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1172\/JCI42980","volume":"120","author":"G Ghosh","year":"2010","unstructured":"Ghosh, G. et al. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-\u03b1 isoforms and promotes angiogenesis. J. Clin. Invest. 120, 4141\u20134154 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201335_CR94","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nature10661","volume":"481","author":"KJ Png","year":"2012","unstructured":"Png, K. J., Halberg, N., Yoshida, M. & Tavazoie, S. F. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481, 190\u2013194 (2012).","journal-title":"Nature"},{"key":"BFnrneph201335_CR95","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/MCB.06643-11","volume":"32","author":"I Mimura","year":"2012","unstructured":"Mimura, I. et al. Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A. Mol. Cell Biol. 32, 3018\u20133032 (2012).","journal-title":"Mol. Cell Biol."},{"key":"BFnrneph201335_CR96","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin, W. G. Jr & Ratcliffe, P. J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393\u2013402 (2008).","journal-title":"Mol. Cell"},{"key":"BFnrneph201335_CR97","doi-asserted-by":"publisher","first-page":"16767","DOI":"10.1074\/jbc.M901790200","volume":"284","author":"DR Mole","year":"2009","unstructured":"Mole, D. R. et al. Genome-wide association of hypoxia-inducible factor (HIF)-1\u03b1 and HIF-2\u03b1 DNA binding with expression profiling of hypoxia-inducible transcripts. J. Biol. Chem. 284, 16767\u201316775 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201335_CR98","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1096\/fj.02-0445fje","volume":"17","author":"MS Wiesener","year":"2003","unstructured":"Wiesener, M. S. et al. Widespread hypoxia-inducible expression of HIF-2\u03b1 in distinct cell populations of different organs. FASEB J. 17, 271\u2013273 (2003).","journal-title":"FASEB J."},{"key":"BFnrneph201335_CR99","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.yexcr.2008.03.003","volume":"314","author":"C Warnecke","year":"2008","unstructured":"Warnecke, C. et al. The specific contribution of hypoxia-inducible factor-2\u03b1 to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp. Cell Res. 314, 2016\u20132027 (2008).","journal-title":"Exp. Cell Res."},{"key":"BFnrneph201335_CR100","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/emboj\/cdg117","volume":"22","author":"M Morita","year":"2003","unstructured":"Morita, M. et al. HLF\/HIF-2\u03b1 is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J. 22, 1134\u20131146 (2003).","journal-title":"EMBO J."},{"key":"BFnrneph201335_CR101","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1097\/01.ASN.0000017223.49823.2A","volume":"13","author":"C Rosenberger","year":"2002","unstructured":"Rosenberger, C. et al. Expression of hypoxia-inducible factor-1\u03b1 and -2\u03b1 in hypoxic and ischemic rat kidneys. J. Am. Soc. Nephrol. 13, 1721\u20131732 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR102","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1681\/ASN.2011020130","volume":"23","author":"P Singh","year":"2012","unstructured":"Singh, P. et al. Aberrant tubuloglomerular feedback and HIF-1\u03b1 confer resistance to ischemia after subtotal nephrectomy. J. Am. Soc. Nephrol. 23, 483\u2013493 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR103","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.ki.5002567","volume":"73","author":"C Rosenberger","year":"2008","unstructured":"Rosenberger, C. et al. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int. 73, 34\u201342 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR104","first-page":"3810","volume":"117","author":"DF Higgins","year":"2007","unstructured":"Higgins, D. F. et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 117, 3810\u20133820 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201335_CR105","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/labinvest.2008.158","volume":"89","author":"M Rudnicki","year":"2009","unstructured":"Rudnicki, M. et al. Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab. Invest. 89, 337\u2013346 (2009).","journal-title":"Lab. Invest."},{"key":"BFnrneph201335_CR106","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/CIRCULATIONAHA.108.788653","volume":"119","author":"AR Chade","year":"2009","unstructured":"Chade, A. R. et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 119, 547\u2013557 (2009).","journal-title":"Circulation"},{"key":"BFnrneph201335_CR107","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1681\/ASN.2005090918","volume":"17","author":"P Katavetin","year":"2006","unstructured":"Katavetin, P. et al. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor\/hypoxia-responsible element pathway. J. Am. Soc. Nephrol. 17, 1405\u20131413 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR108","doi-asserted-by":"publisher","first-page":"10930","DOI":"10.1074\/jbc.M707451200","volume":"283","author":"DJ Ceradini","year":"2008","unstructured":"Ceradini, D. J. et al. Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J. Biol. Chem. 283, 10930\u201310938 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201335_CR109","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/labinvest.2011.114","volume":"91","author":"CK Chiang","year":"2011","unstructured":"Chiang, C. K., Tanaka, T., Inagi, R., Fujita, T. & Nangaku, M. Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner. Lab. Invest. 91, 1564\u20131571 (2011).","journal-title":"Lab. Invest."},{"key":"BFnrneph201335_CR110","first-page":"221","volume":"435","author":"WM Bernhardt","year":"2007","unstructured":"Bernhardt, W. M. et al. Organ protection by hypoxia and hypoxia-inducible factors. Methods Enzymol. 435, 221\u2013245 (2007).","journal-title":"Methods Enzymol."},{"key":"BFnrneph201335_CR111","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/MNH.0b013e3283328eed","volume":"19","author":"T Tanaka","year":"2010","unstructured":"Tanaka, T. & Nangaku, M. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1\u03b1 in progression of chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 19, 43\u201350 (2010).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph201335_CR112","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/labinvest.3700328","volume":"85","author":"T Tanaka","year":"2005","unstructured":"Tanaka, T. et al. Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. Lab. Invest. 85, 1292\u20131307 (2005).","journal-title":"Lab. Invest."},{"key":"BFnrneph201335_CR113","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/ndt\/gfp454","volume":"25","author":"YR Song","year":"2010","unstructured":"Song, Y. R. et al. Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. Nephrol. Dial. Transplant. 25, 77\u201385 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201335_CR114","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1440-1797.2011.01498.x","volume":"17","author":"X Yu","year":"2012","unstructured":"Yu, X. et al. Transient hypoxia-inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine. Nephrology (Carlton) 17, 58\u201367 (2012).","journal-title":"Nephrology (Carlton)"},{"key":"BFnrneph201335_CR115","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1111\/j.1523-1755.2005.00742.x","volume":"68","author":"T Tanaka","year":"2005","unstructured":"Tanaka, T. et al. Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis. Kidney Int. 68, 2714\u20132725 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR116","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.4049\/jimmunol.1103377","volume":"188","author":"H Kobayashi","year":"2012","unstructured":"Kobayashi, H. et al. Myeloid cell-derived hypoxia-inducible factor attenuates inflammation in unilateral ureteral obstruction-induced kidney injury. J. Immunol. 188, 5106\u20135115 (2012).","journal-title":"J. Immunol."},{"key":"BFnrneph201335_CR117","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2010121249","volume":"22","author":"G Schley","year":"2011","unstructured":"Schley, G. et al. Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury. J. Am. Soc. Nephrol. 22, 2004\u20132015 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR118","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1681\/ASN.2006060639","volume":"18","author":"I Kojima","year":"2007","unstructured":"Kojima, I. et al. Protective role of hypoxia-inducible factor-2\u03b1 against ischemic damage and oxidative stress in the kidney. J. Am. Soc. Nephrol. 18, 1218\u20131226 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR119","doi-asserted-by":"publisher","first-page":"F1342","DOI":"10.1152\/ajprenal.00674.2011","volume":"302","author":"AR Chade","year":"2012","unstructured":"Chade, A. R. & Kelsen, S. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach. Am. J. Physiol. Renal Physiol. 302, F1342\u2013F1350 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201335_CR120","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0140-6736(96)03361-2","volume":"348","author":"JM Isner","year":"1996","unstructured":"Isner, J. M. et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348, 370\u2013374 (1996).","journal-title":"Lancet"},{"key":"BFnrneph201335_CR121","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina, V. et al. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129\u20131136 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201335_CR122","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/joim.12019","volume":"273","author":"L Claesson-Welsh","year":"2013","unstructured":"Claesson-Welsh, L. & Welsh, M. VEGFA and tumour angiogenesis. J. Intern. Med. 273, 114\u2013127 (2013).","journal-title":"J. Intern. Med."},{"key":"BFnrneph201335_CR123","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.2337\/diabetes.51.10.3090","volume":"51","author":"A Flyvbjerg","year":"2002","unstructured":"Flyvbjerg, A. et al. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51, 3090\u20133094 (2002).","journal-title":"Diabetes"},{"key":"BFnrneph201335_CR124","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2337\/diabetes.53.7.1831","volume":"53","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto, Y. et al. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 53, 1831\u20131840 (2004).","journal-title":"Diabetes"},{"key":"BFnrneph201335_CR125","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.2337\/diabetes.54.10.2891","volume":"54","author":"K Ichinose","year":"2005","unstructured":"Ichinose, K. et al. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 54, 2891\u20132903 (2005).","journal-title":"Diabetes"},{"key":"BFnrneph201335_CR126","unstructured":"Grutzmacher, C. et al. Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with short duration of diabetes. Am. J. Physiol. Renal Physiol. (2012)."},{"key":"BFnrneph201335_CR127","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/35091000","volume":"412","author":"J LeCouter","year":"2001","unstructured":"LeCouter, J. et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412, 877\u2013884 (2001).","journal-title":"Nature"},{"key":"BFnrneph201335_CR128","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1172\/JCI17712","volume":"112","author":"ME Reinders","year":"2003","unstructured":"Reinders, M. E. et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J. Clin. Invest. 112, 1655\u20131665 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201335_CR129","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nm731","volume":"8","author":"A Luttun","year":"2002","unstructured":"Luttun, A. et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8, 831\u2013840 (2002).","journal-title":"Nat. Med."},{"key":"BFnrneph201335_CR130","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1015587423262","volume":"19","author":"C Brigati","year":"2002","unstructured":"Brigati, C., Noonan, D. M., Albini, A. & Benelli, R. Tumors and inflammatory infiltrates: friends or foes? Clin. Exp. Metastasis 19, 247\u2013258 (2002).","journal-title":"Clin. Exp. Metastasis"},{"key":"BFnrneph201335_CR131","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ki.2008.179","volume":"74","author":"DA Long","year":"2008","unstructured":"Long, D. A. et al. Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Kidney Int. 74, 300\u2013309 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR132","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1152\/physiolgenomics.00048.2006","volume":"27","author":"AC Aplin","year":"2006","unstructured":"Aplin, A. C., Gelati, M., Fogel, E., Carnevale, E. & Nicosia, R. F. Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis. Physiol. Genomics 27, 20\u201328 (2006).","journal-title":"Physiol. Genomics"},{"key":"BFnrneph201335_CR133","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","volume":"8","author":"M De Palma","year":"2005","unstructured":"De Palma, M. et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211\u2013226 (2005).","journal-title":"Cancer Cell"},{"key":"BFnrneph201335_CR134","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1182\/blood-2004-09-3531","volume":"105","author":"C Lemieux","year":"2005","unstructured":"Lemieux, C. et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 105, 1523\u20131530 (2005).","journal-title":"Blood"},{"key":"BFnrneph201335_CR135","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1152\/ajprenal.90430.2008","volume":"296","author":"W Mu","year":"2009","unstructured":"Mu, W. et al. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism. Am. J. Physiol. Renal Physiol. 296, F145\u2013F152 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201335_CR136","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1167\/iovs.11-8114","volume":"53","author":"S Nakao","year":"2012","unstructured":"Nakao, S. et al. Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltration. Invest. Ophthalmol. Vis. Sci. 53, 3296\u20133302 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrneph201335_CR137","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1167\/iovs.11-9119","volume":"53","author":"S Nakao","year":"2012","unstructured":"Nakao, S. et al. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis. Invest. Ophthalmol. Vis. Sci. 53, 4323\u20134328 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrneph201335_CR138","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/archopht.126.6.782","volume":"126","author":"O Tatar","year":"2008","unstructured":"Tatar, O. et al. Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization. Arch. Ophthalmol. 126, 782\u2013790 (2008).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrneph201335_CR139","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1067\/mhj.2001.118471","volume":"142","author":"TD Henry","year":"2001","unstructured":"Henry, T. D. et al. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am. Heart J. 142, 872\u2013880 (2001).","journal-title":"Am. Heart J."},{"key":"BFnrneph201335_CR140","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","volume":"454","author":"S Reitsma","year":"2007","unstructured":"Reitsma, S., Slaaf, D. W., Vink, H., van Zandvoort, M. A. & oude Egbrink, M. G. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 454, 345\u2013359 (2007).","journal-title":"Pflugers Arch."},{"key":"BFnrneph201335_CR141","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/clin.1994.1018","volume":"70","author":"S Shibata","year":"1994","unstructured":"Shibata, S., Sasaki, T., Harpel, P. & Fillit, H. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes. Clin. Immunol. Immunopathol. 70, 114\u2013123 (1994).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"BFnrneph201335_CR142","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1681\/ASN.2005020137","volume":"16","author":"N Eto","year":"2005","unstructured":"Eto, N. et al. Protection of endothelial cells by dextran sulfate in rats with thrombotic microangiopathy. J. Am. Soc. Nephrol. 16, 2997\u20133005 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR143","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1101\/gad.914801","volume":"15","author":"DA Elson","year":"2001","unstructured":"Elson, D. A. et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1\u03b1. Genes Dev. 15, 2520\u20132532 (2001).","journal-title":"Genes Dev."},{"key":"BFnrneph201335_CR144","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","volume":"136","author":"M Mazzone","year":"2009","unstructured":"Mazzone, M. et al. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136, 839\u2013851 (2009).","journal-title":"Cell"},{"key":"BFnrneph201335_CR145","doi-asserted-by":"publisher","first-page":"F1132","DOI":"10.1152\/ajprenal.00163.2006","volume":"292","author":"PE Westerweel","year":"2007","unstructured":"Westerweel, P. E. et al. End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am. J. Physiol. Renal Physiol. 292, F1132\u2013F1140 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201335_CR146","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/stem.426","volume":"28","author":"AR Chade","year":"2010","unstructured":"Chade, A. R. et al. Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells 28, 1039\u20131047 (2010).","journal-title":"Stem Cells"},{"key":"BFnrneph201335_CR147","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1681\/ASN.2009111119","volume":"21","author":"MS Goligorsky","year":"2010","unstructured":"Goligorsky, M. S., Yasuda, K. & Ratliff, B. Dysfunctional endothelial progenitor cells in chronic kidney disease. J. Am. Soc. Nephrol. 21, 911\u2013919 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR148","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/01.CIR.0000139335.04152.F3","volume":"110","author":"FH Bahlmann","year":"2004","unstructured":"Bahlmann, F. H. et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin \u03b1 persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 110, 1006\u20131012 (2004).","journal-title":"Circulation"},{"key":"BFnrneph201335_CR149","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/ki.2012.105","volume":"82","author":"V Cantaluppi","year":"2012","unstructured":"Cantaluppi, V. et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia\u2013reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 82, 412\u2013427 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201335_CR150","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1681\/ASN.2008070798","volume":"20","author":"S Bruno","year":"2009","unstructured":"Bruno, S. et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20, 1053\u20131067 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201335_CR151","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/ndt\/gfr015","volume":"26","author":"S Gatti","year":"2011","unstructured":"Gatti, S. et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant. 26, 1474\u20131483 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201335_CR152","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph201335_CR153","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1038\/emboj.2012.183","volume":"31","author":"G Zhuang","year":"2012","unstructured":"Zhuang, G. et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 31, 3513\u20133523 (2012).","journal-title":"EMBO J."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.35","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:42:27Z","timestamp":1684471347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2013.35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,5]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFnrneph201335"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2013.35","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,5]]}}}